Senior Application Consultant at Capgemini Americas
United States
Sudeepta Rana
Council Member
Sudeepta Rana is a Senior SAP S/4HANA Business Transformation Advisor and OTC Functional Architect with 17 years of experience conducting applied research in enterprise systems and pharmaceutical supply chain optimization. With an MBA in Sales and Marketing and a Bachelor of Pharmacy, Sudeepta Rana has built expertise across regulated Life Sciences, Pharmaceutical, Retail, Manufacturing, and FMCG environments, working primarily at Capgemini Americas, IBM Corporation, and ITC Infotech. Her work follows systematic scientific methodology: defining problem states through AS-IS analysis, formulating solutions through blueprint and design investigation, validating through controlled testing environments, and measuring outcomes against quantifiable benchmarks. Her research interests include enterprise digital transformation, AI-supplemented supply chain analytics, regulatory compliance automation in ERP environments, and human-centered system design in clinical supply chains.
Currently working as Senior Application Consultant and Onshore OTC Team Lead at Capgemini Americas in the Life Sciences, Healthcare, Pharmaceutical, and Molecular Genetics division since August 2022, Sudeepta Rana acts as principal investigator on the S/4HANA 2023 transformation program. She led the original design and architecture of the client's Jurisdiction Control Product team, a configuration domain with no existing S/4HANA precedent in the regulated environment. She designed the original OTC functional architecture for S/4HANA 2023 Jurisdiction Control transformation, defined research parameters through systematic gap analysis between legacy ECC processes and S/4HANA data model, and validated findings through iterative sandbox experimentation. She served as OTC Functional Architect and Lead for the XPS upgrade project and S/4HANA technical migration, designing system integration architecture from first principles where no prior blueprint existed. She led the OTC functional investigation for the client's S/4HANA conversion Proof of Concept and Transportation Management project, functioning as principal investigator by defining feasibility questions, configuring experimental environments, and measuring conversion outcomes. She designed and recommended original interfaces automating previously manual business processes, with each interface design constituting an original applied engineering contribution. She facilitated stakeholder workshops translating complex technical findings into business decisions, managed risk, escalation, and scope through DevOps, and authored primary technical documentation including process blueprints, break-fix analyses, and change control records serving as replicable research artifacts. She led a cross-functional team that delivered a 30% OTC efficiency improvement with quantified and documented outcomes.
From February 2022 to August 2022, Sudeepta Rana served as Advisory Technical Services Specialist and Onshore Business Analyst at IBM Corporation in the Life Sciences, Pharmaceutical, and Healthcare division. She led the Business Process and System Improvement team, developing and applying data analytics frameworks to identify, validate, and implement supply chain improvement opportunities using hypothesis-driven applied research methodology. As principal investigator for the SDDC migration, she conducted systematic current-state analysis, failure mode identification, and remediation architecture design. She led Wave 1 and Wave 2 implementations for Projects Valiant and Liberty, designing a consumer/customer order portal solution via SAP Hybris, conducting original operations research into picking strategy optimization across multiple physical warehouses, and designing a loaner set management system for the Surgical Essential Medical Devices division. As principal investigator for the Canada MD Contract Management System, she defined problem scope, designed solution architecture, and measured outcomes across three target metrics including strategic pricing accuracy, resource utilization, and contract compliance, leading to price erosion mitigation and improved planning cycle performance. She developed and validated the business case for road freight optimization for ISGT/RDSC through empirical cost-benefit analysis with measurable implementation outcomes enabling low-cost freight shipments.
From October 2018 to February 2022, Sudeepta Rana worked as OTC Functional Lead at IBM India Pvt Ltd in Retail, Apparel, and Footwear. She conducted systematic L2/L3 investigative analysis of complex SAP-to-non-SAP interface failures across EDI/IDocs and GIS/WM systems, developing replicable resolution methodologies codified as organizational SOPs and Knowledge Transfer documents. She led original functional investigation into allocation and deallocation enhancement requirements and authored functional design specifications introducing new system capabilities not previously available in the client environment. She managed bidirectional knowledge transition between client and support organization and served as primary author of SOP and KT documentation serving as transferable institutional research artifacts.
From January 2015 to September 2018, Sudeepta Rana held the position of Senior Consultant and Global Shift Ticket Lead at Capgemini Technology Services India Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She conducted systematic root-cause analysis investigations on complex SD, Shipping, MM (STO), and GTS failures, with findings documented in globally adopted SOPs influencing cross-national support methodology with reproducible investigative outcomes. She served as primary author of functional specifications for user exits and custom reports, creating original applied engineering documents translating novel business requirements into system-level solutions. She investigated and optimized multi-system interfaces between SAP R/3 and legacy environments including ECMS, CCMS, IVRS, DEVODS, and LSP through applied systems integration research with documented outcomes. She supervised and mentored a cross-national investigative team of 10 members across India and Brazil, coordinating parallel research streams under SLA constrained conditions. She managed test cases, test plans, and defect tracking via HP Quality Center, designing and executing structured empirical validation protocols.
Currently working as Senior Application Consultant and Onshore OTC Team Lead at Capgemini Americas in the Life Sciences, Healthcare, Pharmaceutical, and Molecular Genetics division since August 2022, Sudeepta Rana acts as principal investigator on the S/4HANA 2023 transformation program. She led the original design and architecture of the client's Jurisdiction Control Product team, a configuration domain with no existing S/4HANA precedent in the regulated environment. She designed the original OTC functional architecture for S/4HANA 2023 Jurisdiction Control transformation, defined research parameters through systematic gap analysis between legacy ECC processes and S/4HANA data model, and validated findings through iterative sandbox experimentation. She served as OTC Functional Architect and Lead for the XPS upgrade project and S/4HANA technical migration, designing system integration architecture from first principles where no prior blueprint existed. She led the OTC functional investigation for the client's S/4HANA conversion Proof of Concept and Transportation Management project, functioning as principal investigator by defining feasibility questions, configuring experimental environments, and measuring conversion outcomes. She designed and recommended original interfaces automating previously manual business processes, with each interface design constituting an original applied engineering contribution. She facilitated stakeholder workshops translating complex technical findings into business decisions, managed risk, escalation, and scope through DevOps, and authored primary technical documentation including process blueprints, break-fix analyses, and change control records serving as replicable research artifacts. She led a cross-functional team that delivered a 30% OTC efficiency improvement with quantified and documented outcomes.
From February 2022 to August 2022, Sudeepta Rana served as Advisory Technical Services Specialist and Onshore Business Analyst at IBM Corporation in the Life Sciences, Pharmaceutical, and Healthcare division. She led the Business Process and System Improvement team, developing and applying data analytics frameworks to identify, validate, and implement supply chain improvement opportunities using hypothesis-driven applied research methodology. As principal investigator for the SDDC migration, she conducted systematic current-state analysis, failure mode identification, and remediation architecture design. She led Wave 1 and Wave 2 implementations for Projects Valiant and Liberty, designing a consumer/customer order portal solution via SAP Hybris, conducting original operations research into picking strategy optimization across multiple physical warehouses, and designing a loaner set management system for the Surgical Essential Medical Devices division. As principal investigator for the Canada MD Contract Management System, she defined problem scope, designed solution architecture, and measured outcomes across three target metrics including strategic pricing accuracy, resource utilization, and contract compliance, leading to price erosion mitigation and improved planning cycle performance. She developed and validated the business case for road freight optimization for ISGT/RDSC through empirical cost-benefit analysis with measurable implementation outcomes enabling low-cost freight shipments.
From October 2018 to February 2022, Sudeepta Rana worked as OTC Functional Lead at IBM India Pvt Ltd in Retail, Apparel, and Footwear. She conducted systematic L2/L3 investigative analysis of complex SAP-to-non-SAP interface failures across EDI/IDocs and GIS/WM systems, developing replicable resolution methodologies codified as organizational SOPs and Knowledge Transfer documents. She led original functional investigation into allocation and deallocation enhancement requirements and authored functional design specifications introducing new system capabilities not previously available in the client environment. She managed bidirectional knowledge transition between client and support organization and served as primary author of SOP and KT documentation serving as transferable institutional research artifacts.
From January 2015 to September 2018, Sudeepta Rana held the position of Senior Consultant and Global Shift Ticket Lead at Capgemini Technology Services India Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She conducted systematic root-cause analysis investigations on complex SD, Shipping, MM (STO), and GTS failures, with findings documented in globally adopted SOPs influencing cross-national support methodology with reproducible investigative outcomes. She served as primary author of functional specifications for user exits and custom reports, creating original applied engineering documents translating novel business requirements into system-level solutions. She investigated and optimized multi-system interfaces between SAP R/3 and legacy environments including ECMS, CCMS, IVRS, DEVODS, and LSP through applied systems integration research with documented outcomes. She supervised and mentored a cross-national investigative team of 10 members across India and Brazil, coordinating parallel research streams under SLA constrained conditions. She managed test cases, test plans, and defect tracking via HP Quality Center, designing and executing structured empirical validation protocols.
From October 2013 to December 2014, Sudeepta Rana worked as Senior Consultant and Carrier Integration & OTC Configuration Lead at IBM India Pvt Ltd in Pharmaceutical, Manufacturing, and Molecular Genetics. She led a testing team designing and executing unit, integration, and UAT protocols for SD/MM modules (STO/TO) using systematic empirical validation methodology applied to complex pharmaceutical OTC environments. She conducted original carrier/shipper configuration research across SAP, XPS, and CS systems, with outcomes documented and transferred to the Cepheid IS team as replicable knowledge artifacts. She guided junior consultants in OTC configuration methodology and served as primary author of super user and end-user training documentation.
From March 2013 to September 2013, Sudeepta Rana served as Senior Consultant for the GSK Multi-Country OTC Rollout at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She designed and implemented original enterprise OTC architecture simultaneously across 14 GSK countries, tackling a large-scale multi-variable applied research problem with no existing organizational template. She conducted original geo-coding investigation, configuring and validating latitude/longitude precision addressing for large-format cities across 14 international jurisdictions and designing country/region-level geo-coding assignment methodology now replicable across similar implementations. She designed intercompany billing structures, credit control area mapping, and sales order type permissions for all 14 entities, and defined the internal customer framework for the inter-company billing process.
From November 2012 to February 2013, Sudeepta Rana worked as Senior Consultant for the Ireland OTC & GTS Rollout at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She conducted AS-IS/TO-BE investigative analysis and original blueprint design for the Ireland entity through systematic current-state documentation, gap identification, future-state design, configuration, and empirical validation. She designed original GTS architecture for Ireland including legal unit creation, plant assignment to feeder system, legal regulation design, commodity code configuration, and customs duty framework as regulatory compliance engineering with no existing client template. She designed a novel carrier label system in XPS for DHL and UPS with original international bill of lading output type and configured batch job automation for print processing. She updated Z-table enhancements for intercompany invoice number ranges and delivery number captured in accounting documents through original ABAP-functional hybrid design.
From August 2011 to October 2012, Sudeepta Rana served as Senior Consultant for Amgen CDSS-R Clinical Supply Chain at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She designed and implemented a novel STO serial number assignment enhancement for clinical trial supply, representing an original application of SAP functionality to a regulated clinical environment. She designed a regulatory-compliant ATP enhancement enforcing country-approval validation gates, an original investigation with no prior published methodology. She architected the RIPD portal solution enabling external study managers (non-Amgen personnel) to manage return orders, representing original human-centered system design in a regulated pharmaceutical context. She designed a clinical reconciliation data collection and reporting enhancement as an original data management framework for clinical supply chain. She investigated and maintained multi-system integration between IVRS suppliers and the DevODS master data system.
From March 2013 to September 2013, Sudeepta Rana served as Senior Consultant for the GSK Multi-Country OTC Rollout at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She designed and implemented original enterprise OTC architecture simultaneously across 14 GSK countries, tackling a large-scale multi-variable applied research problem with no existing organizational template. She conducted original geo-coding investigation, configuring and validating latitude/longitude precision addressing for large-format cities across 14 international jurisdictions and designing country/region-level geo-coding assignment methodology now replicable across similar implementations. She designed intercompany billing structures, credit control area mapping, and sales order type permissions for all 14 entities, and defined the internal customer framework for the inter-company billing process.
From November 2012 to February 2013, Sudeepta Rana worked as Senior Consultant for the Ireland OTC & GTS Rollout at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She conducted AS-IS/TO-BE investigative analysis and original blueprint design for the Ireland entity through systematic current-state documentation, gap identification, future-state design, configuration, and empirical validation. She designed original GTS architecture for Ireland including legal unit creation, plant assignment to feeder system, legal regulation design, commodity code configuration, and customs duty framework as regulatory compliance engineering with no existing client template. She designed a novel carrier label system in XPS for DHL and UPS with original international bill of lading output type and configured batch job automation for print processing. She updated Z-table enhancements for intercompany invoice number ranges and delivery number captured in accounting documents through original ABAP-functional hybrid design.
From August 2011 to October 2012, Sudeepta Rana served as Senior Consultant for Amgen CDSS-R Clinical Supply Chain at IBM India Pvt Ltd in Life Sciences, Pharmaceutical, and Molecular Genetics. She designed and implemented a novel STO serial number assignment enhancement for clinical trial supply, representing an original application of SAP functionality to a regulated clinical environment. She designed a regulatory-compliant ATP enhancement enforcing country-approval validation gates, an original investigation with no prior published methodology. She architected the RIPD portal solution enabling external study managers (non-Amgen personnel) to manage return orders, representing original human-centered system design in a regulated pharmaceutical context. She designed a clinical reconciliation data collection and reporting enhancement as an original data management framework for clinical supply chain. She investigated and maintained multi-system integration between IVRS suppliers and the DevODS master data system.